se ha leído el artículo
array:24 [ "pii" => "S1578219018304141" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.11.016" "estado" => "S300" "fechaPublicacion" => "2019-01-01" "aid" => "1916" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:64-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731018300784" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.11.014" "estado" => "S300" "fechaPublicacion" => "2019-01-01" "aid" => "1916" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:64-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 285 "formatos" => array:2 [ "HTML" => 123 "PDF" => 162 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científico-clínica</span>" "titulo" => "Erupción dermatomiositis-<span class="elsevierStyleItalic">like</span> en una paciente tratada con hidroxiurea" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "64" "paginaFinal" => "67" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Dermatomyositis-like Eruption in a Woman Treated With Hydroxyurea" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1021 "Ancho" => 1750 "Tamanyo" => 204188 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Eritema periorbitario en heliotropo. B) Prominentes telangiectasias periungueales. C) Placa eritemato-descamativa sobre la rodilla. D) Lesiones eritemato-descamativas en el dorso de las articulaciones interfalángicas y metacarpofalángicas. E) Placa eritemato-descamativa en los glúteos. F) Lesiones eritemato-descamativas en el dorso y cara lateral de ambos pies.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "E. Moreno-Artero, J.J. Paricio, J. Antoñanzas, A. España" "autores" => array:4 [ 0 => array:2 [ "nombre" => "E." "apellidos" => "Moreno-Artero" ] 1 => array:2 [ "nombre" => "J.J." "apellidos" => "Paricio" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Antoñanzas" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "España" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219018304141" "doi" => "10.1016/j.adengl.2018.11.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304141?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018300784?idApp=UINPBA000044" "url" => "/00017310/0000011000000001/v1_201901030610/S0001731018300784/v1_201901030610/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S157821901830413X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.11.015" "estado" => "S300" "fechaPublicacion" => "2019-01-01" "aid" => "1913" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:67-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 2 "PDF" => 1 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Allergic Contact Dermatitis Due to Methyl Glucose Dioleate in a Balm Cream" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "67" "paginaFinal" => "68" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Eczema alérgico de contacto por metil glucosa dioleato contenido en una crema bálsamo" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1219 "Ancho" => 800 "Tamanyo" => 77544 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Erythematous, scaly plaques on the axillas.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "T. Sanz-Sánchez, R.M. Díaz-Díaz, C. Garrido Gutiérrez, V. Leis Dosil" "autores" => array:4 [ 0 => array:2 [ "nombre" => "T." "apellidos" => "Sanz-Sánchez" ] 1 => array:2 [ "nombre" => "R.M." "apellidos" => "Díaz-Díaz" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Garrido Gutiérrez" ] 3 => array:2 [ "nombre" => "V." "apellidos" => "Leis Dosil" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018300759" "doi" => "10.1016/j.ad.2017.11.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018300759?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901830413X?idApp=UINPBA000044" "url" => "/15782190/0000011000000001/v1_201901030631/S157821901830413X/v1_201901030631/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219018304025" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.11.006" "estado" => "S300" "fechaPublicacion" => "2019-01-01" "aid" => "1908" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:63-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7 "formatos" => array:2 [ "HTML" => 3 "PDF" => 4 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Mastocytosis With Associated Essential Thrombocythemia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "63" "paginaFinal" => "64" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Mastocitosis asociada a trombocitemia esencial" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1031 "Ancho" => 1517 "Tamanyo" => 216050 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical appearance of maculopapular mastocytosis lesions on the thighs (A) and forearm (B).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Marcoval" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Marcoval" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S000173101830070X" "doi" => "10.1016/j.ad.2017.10.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101830070X?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304025?idApp=UINPBA000044" "url" => "/15782190/0000011000000001/v1_201901030631/S1578219018304025/v1_201901030631/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Dermatomyositis-like Eruption in a Woman Treated With Hydroxyurea" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">To the Editor:</span>" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "64" "paginaFinal" => "67" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "E. Moreno-Artero, J.J. Paricio, J. Antoñanzas, A. España" "autores" => array:4 [ 0 => array:4 [ "nombre" => "E." "apellidos" => "Moreno-Artero" "email" => array:1 [ 0 => "emartero@unav.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "J.J." "apellidos" => "Paricio" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "J." "apellidos" => "Antoñanzas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "A." "apellidos" => "España" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Departamento de Dermatología, Clínica Universidad de Navarra, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, España" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Departamento de Anatomía Patológica, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Navarra, España" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Departamento de Dermatología, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Navarra, España" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Erupción dermatomiositis-<span class="elsevierStyleItalic">like</span> en una paciente tratada con hidroxiurea" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2014 "Ancho" => 1517 "Tamanyo" => 1032354 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A and B, Histopathology reveals parakeratosis, mild epidermal atrophy, lymphocytic exocytosis, and foci of vacuolization in the basement layer, with occasional apoptotic keratinocytes (hematoxylin-eosin, original magnification<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>4,<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10). C, Vascular proliferation and mild fibrosis in the dermis. No keratinocyte atypia or overexpression of p53 is observed (hematoxylin-eosin, original magnification<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>20). D, Abundant interstitial acid mucin deposits can be observed (colloidal iron, original magnification<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Dermatomyositis is an idiopathic inflammatory myopathy that usually progresses with inflammation of the skin and skeletal muscle. However, there are hypomyopathic and amyopathic forms that progress without laboratory abnormalities and/or muscle weakness, respectively.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">1,2</span></a> While the cause is not generally known, some forms can be induced or exacerbated by drugs.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a> We report a case of dermatomyositis-like eruption with no muscle involvement associated with hydroxyurea and review specific immunological, clinical, and epidemiological findings.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The patient was a 63-year-old woman diagnosed with essential thrombocytopenia who had been receiving treatment with hydroxyurea since 2010. She was evaluated at the dermatology clinic for a 3-year history of erythematous, scaly lesions on the dorsum of the interphalangeal and metacarpophalangeal joints of the hands, dorsum of the feet, elbows, knees, and presternal area (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). No muscular weakness or other remarkable cutaneous or mucosal manifestations were observed.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">The histopathology findings are shown in <a class="elsevierStyleCrossRef" href="#fig0010">Figure 2</a>. The laboratory workup revealed normal results for inflammatory parameters and muscle enzymes. Negative results were recorded for myositis-specific antibodies (anti-Mi2, anti-MDA5, anti–SAE, anti-TIF, anti–NXP-2, anti-t-RNA-synthetase, anti–PMS, anti–SSA/Ro, anti-U1RNP, anti-Pm-Scl, and anti-Ku) and for antinuclear antibodies.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">On the basis of these findings, the patient was diagnosed with dermatomyositis-like eruption secondary to treatment with hydroxyurea, and, given the hematology report, we opted to suspend treatment. The lesions were in remission at 3 months, although the increased platelet count obliged us to reintroduce the medication, thus exacerbating the lesions again.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Dermatomyositis secondary to drugs is an uncommon condition. The drugs involved include hydroxyurea, statins, terbinafine, and anti–tumor necrosis factor agents.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">3,4</span></a> With no distinctions between drugs, the forms induced by medications carry a 39% risk of muscle involvement, which is lower than in the classic forms, and up to 50% of patients also have cancer or an underlying autoimmune disease. Furthermore, the disease usually affects patients taking multiple medications for their underlying condition.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a> Consequently, diagnosis is truly challenging for 2 reasons: it is difficult to determine which drug is involved and it is complicated to determine whether dermatomyositis is related to the drug or to the underlying cancer or rheumatic disease. In addition, given that paraneoplastic dermatomyositis is amyopathic in almost 60% of cases<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a> and that muscle involvement in drug-related forms is uncommon, the differential diagnosis is, if anything, somewhat more complex.</p><p id="par0030" class="elsevierStylePara elsevierViewall">In the first place, it is important to know which drug is responsible. Hydroxyurea is the most commonly involved drug (50% of cases)<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a> and presents specific features with respect to other drugs, as shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a> In clinical terms, in addition to the typical cutaneous manifestations of classic dermatomyositis, the presence of cutaneous-mucosal manifestations associated with hydroxyurea (eg, xerosis, atrophy, stomatitis, ulceration, and melanonychia) is habitual.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">3–5</span></a> Histopathology findings are indistinguishable from those found in classic dermatomyositis, although, in some cases, there have been reports of changes suggestive of hydroxyurea-induced squamous dysplasia, such as keratinocyte atypia and overexpression of p53. According to some authors, the condition carries a risk of progression to cutaneous squamous cell carcinoma, which would require close follow-up of patients in the long term and withdrawal of the drug when dermatomyositis appears.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">Immunosuppressive treatment is not usually necessary, and suspension of hydroxyurea is generally sufficient to achieve remission of the clinical condition. However, immunosuppressive treatment is necessary in cases secondary to other drugs.</p><p id="par0040" class="elsevierStylePara elsevierViewall">The second challenge is to determine whether the underlying neoplasm itself or a drug is responsible for the clinical condition. This is especially difficult with hydroxyurea, since it is not associated with muscle involvement and, as we have already said, paraneoplastic dermatomyositis is amyopathic in most cases.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a> The most indicative parameter for differentiating this condition seems to be the time between onset of dermatomyositis and diagnosis of the tumor. Paraneoplastic symptoms generally appear during the first 2 years after diagnosis of the tumor, especially during the first 7 months. In the case of drug-associated cases, only 37% are diagnosed during the first 3 years, whereas 78% appear during the first 5 years.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a> In the present case, the interval was 40 months, which is far from the mean time reported for paraneoplastic cases.</p><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion, dermatomyositis-like eruption associated with hydroxyurea is not a true myopathy for 2 reasons: first, it is not an immune-mediated condition, as seen in the low frequency of antinuclear antibodies; and second, it is not associated with muscle weakness. While the etiology is unknown, some authors defend the presence of factors other than those of the drug itself, such as the tumor in which the drug is used as treatment and the potential role of the interaction between UV radiation and hydroxyurea, which could indicate a phototoxic reaction.<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">4,5</span></a> Similarly, it is worth pointing out the risk of developing cutaneous squamous cell carcinoma.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a> Lastly, it is important to distinguish the eruption from amyopathic paraneoplastic dermatomyositis owing to its better prognosis and different therapeutic management.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of Interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Moreno-Artero E, Paricio JJ, Antoñanzas J, España A. Erupción dermatomiositis-<span class="elsevierStyleItalic">like</span> en una paciente tratada con hidroxiurea. Actas Dermosifiliogr. 2019;110:64–67.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1021 "Ancho" => 1750 "Tamanyo" => 204188 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Periorbital heliotrope rash. B, Prominent periungual telangiectases. C, Erythematous, scaly plaque on the knee. D, Erythematous, scaly lesions on the dorsum of the interphalangeal and metacarpophalangeal joints. E, Erythematous, scaly plaque on the buttocks. F, Erythematous, scaly lesions on the dorsum and lateral aspect of the feet.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2014 "Ancho" => 1517 "Tamanyo" => 1032354 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A and B, Histopathology reveals parakeratosis, mild epidermal atrophy, lymphocytic exocytosis, and foci of vacuolization in the basement layer, with occasional apoptotic keratinocytes (hematoxylin-eosin, original magnification<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>4,<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10). C, Vascular proliferation and mild fibrosis in the dermis. No keratinocyte atypia or overexpression of p53 is observed (hematoxylin-eosin, original magnification<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>20). D, Abundant interstitial acid mucin deposits can be observed (colloidal iron, original magnification<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10).</p>" ] ] 2 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: ANA, antinuclear antibodies; DM, dermatomyositis.</p><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Source: Seidler and Gottlieb.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a></p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hydroxyurea-Associated DM \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">DM Associated With Other Drugs \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Median age at diagnosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">61 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Median time since administration of drug until onset of DM, mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">60 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Positive ANA titer, % \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">54 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Muscular symptoms, % \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">79 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Underlying neoplasm, % \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">69 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">18 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Suppression of the drug \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Suppression of the drug<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>immunosuppressant \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1933260.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Main Differences Between Hydroxyurea-Associated DM-like Eruption and DM Caused by Other Drugs.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0035" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The pathogenesis of dermatomyositis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Thompson" 1 => "V. Piguet" 2 => "E. Choy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.15607" "Revista" => array:2 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2017" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0040" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features – a Comprehensive Review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Y. Muro" 1 => "K. Sugiura" 2 => "M. Akiyama" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12016-015-8496-5" "Revista" => array:6 [ "tituloSerie" => "Clin Rev Allergy Immunol" "fecha" => "2016" "volumen" => "51" "paginaInicial" => "293" "paginaFinal" => "302" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26100618" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0045" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hydroxyurea induced dermatomyositis-like eruption" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T.M. Zappala" 1 => "K. Rodins" 2 => "J. Muir" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-0960.2011.00774.x" "Revista" => array:6 [ "tituloSerie" => "Australas J Dermatol" "fecha" => "2012" "volumen" => "53" "paginaInicial" => "e58" "paginaFinal" => "e60" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22881475" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0050" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dermatomyositis-like eruption associated with hydroxyurea therapy: a premalignant condition?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. De Unamuno-Bustos" 1 => "R. Ballester-Sánchez" 2 => "V. Sabater Marco" 3 => "J.J. Vilata-Corell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2014.02.003" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2014" "volumen" => "105" "paginaInicial" => "876" "paginaFinal" => "878" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24666578" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0055" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dermatomyositis induced by drug therapy: A review of case reports" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.M. Seidler" 1 => "A.B. Gottlieb" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2008" "volumen" => "59" "paginaInicial" => "872" "paginaFinal" => "880" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0060" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Paraneoplastic dermatomyositis: A study of 12 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Requena" 1 => "A. Alfaro" 2 => "V. Traves" 3 => "E. Nagore" 4 => "B. Llombart" 5 => "C. Serra" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2013.11.007" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2014" "volumen" => "105" "paginaInicial" => "675" "paginaFinal" => "682" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24484630" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011000000001/v1_201901030631/S1578219018304141/v1_201901030631/en/main.assets" "Apartado" => array:4 [ "identificador" => "6157" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case and Research Letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000001/v1_201901030631/S1578219018304141/v1_201901030631/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304141?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 9 | 14 | 23 |
2024 Octubre | 94 | 64 | 158 |
2024 Septiembre | 105 | 48 | 153 |
2024 Agosto | 122 | 70 | 192 |
2024 Julio | 137 | 56 | 193 |
2024 Junio | 93 | 51 | 144 |
2024 Mayo | 107 | 46 | 153 |
2024 Abril | 91 | 39 | 130 |
2024 Marzo | 102 | 30 | 132 |
2024 Febrero | 77 | 40 | 117 |
2024 Enero | 64 | 34 | 98 |
2023 Diciembre | 71 | 27 | 98 |
2023 Noviembre | 107 | 41 | 148 |
2023 Octubre | 104 | 37 | 141 |
2023 Septiembre | 99 | 36 | 135 |
2023 Agosto | 101 | 25 | 126 |
2023 Julio | 102 | 36 | 138 |
2023 Junio | 71 | 31 | 102 |
2023 Mayo | 96 | 28 | 124 |
2023 Abril | 78 | 20 | 98 |
2023 Marzo | 79 | 30 | 109 |
2023 Febrero | 76 | 31 | 107 |
2023 Enero | 53 | 36 | 89 |
2022 Diciembre | 59 | 43 | 102 |
2022 Noviembre | 38 | 24 | 62 |
2022 Octubre | 30 | 20 | 50 |
2022 Septiembre | 54 | 42 | 96 |
2022 Agosto | 35 | 39 | 74 |
2022 Julio | 33 | 47 | 80 |
2022 Junio | 22 | 40 | 62 |
2022 Mayo | 74 | 33 | 107 |
2022 Abril | 75 | 40 | 115 |
2022 Marzo | 92 | 63 | 155 |
2022 Febrero | 81 | 45 | 126 |
2022 Enero | 73 | 41 | 114 |
2021 Diciembre | 84 | 49 | 133 |
2021 Noviembre | 88 | 51 | 139 |
2021 Octubre | 83 | 70 | 153 |
2021 Septiembre | 65 | 57 | 122 |
2021 Agosto | 74 | 51 | 125 |
2021 Julio | 75 | 45 | 120 |
2021 Junio | 77 | 45 | 122 |
2021 Mayo | 74 | 47 | 121 |
2021 Abril | 114 | 101 | 215 |
2021 Marzo | 83 | 43 | 126 |
2021 Febrero | 83 | 39 | 122 |
2021 Enero | 54 | 36 | 90 |
2020 Diciembre | 68 | 25 | 93 |
2020 Noviembre | 43 | 46 | 89 |
2020 Octubre | 25 | 15 | 40 |
2020 Septiembre | 45 | 23 | 68 |
2020 Agosto | 36 | 27 | 63 |
2020 Julio | 25 | 25 | 50 |
2020 Junio | 31 | 31 | 62 |
2020 Mayo | 23 | 17 | 40 |
2020 Abril | 12 | 10 | 22 |
2020 Marzo | 46 | 8 | 54 |
2020 Febrero | 3 | 0 | 3 |